P. Timothy Noyes's most recent trade in Jade Biosciences Inc was a trade of 10,000 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on May 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 16 May 2024 | 10,000 | 10,000 | - | 2.1 | 21,400 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 10,000 | 343,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 16 May 2024 | 8,707 | 1,293 | - | 21.5 | 187,410 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 21.92 per share. | 16 May 2024 | 1,293 | 0 | - | 21.9 | 28,345 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 01 May 2024 | 10,000 | 10,000 | - | 2.1 | 21,400 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 10,000 | 353,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 20.34 per share. | 01 May 2024 | 9,035 | 965 | - | 20.3 | 183,793 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 19.91 per share. | 01 May 2024 | 1,357 | 0 | - | 19.9 | 27,018 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 20.87 per share. | 01 May 2024 | 965 | 0 | - | 20.9 | 20,135 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 10,000 | 363,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 16 Apr 2024 | 10,000 | 10,000 | - | 2.1 | 21,400 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 24.94 per share. | 16 Apr 2024 | 5,509 | 0 | - | 24.9 | 137,410 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 24.40 per share. | 16 Apr 2024 | 4,491 | 5,509 | - | 24.4 | 109,561 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 01 Apr 2024 | 10,000 | 10,000 | - | 2.1 | 21,400 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 10,000 | 373,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 28.96 per share. | 01 Apr 2024 | 4,502 | 5,498 | - | 29.0 | 130,399 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 31.02 per share. | 01 Apr 2024 | 2,851 | 1,000 | - | 31.0 | 88,446 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 29.90 per share. | 01 Apr 2024 | 1,647 | 3,851 | - | 29.9 | 49,238 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 31.95 per share. | 01 Apr 2024 | 1,000 | 0 | - | 32.0 | 31,950 | Common Stock |
| Jade Biosciences Inc | P. Timothy Noyes | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 28 Jul 2023 | 5,478 | 0 | - | 18 | 98,604 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2023 | 5,478 | 383,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 28 Jul 2023 | 5,478 | 5,478 | - | 2.1 | 11,723 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 17 Jul 2023 | 4,522 | 4,522 | - | 2.1 | 9,677 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 4,522 | 388,859 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 18.11 per share. | 17 Jul 2023 | 4,522 | 0 | - | 18.1 | 81,896 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 03 Jul 2023 | 10,000 | 0 | - | 18 | 180,000 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 10,000 | 393,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 03 Jul 2023 | 10,000 | 10,000 | - | 2.1 | 21,400 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 20.61 per share. | 01 May 2023 | 15,000 | 693 | - | 20.6 | 309,089 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 15,000 | 403,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 01 May 2023 | 15,000 | 15,693 | - | 2.1 | 32,100 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 21.15 per share. | 01 May 2023 | 693 | 0 | - | 21.2 | 14,657 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 15,000 | 418,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 03 Apr 2023 | 15,000 | 15,000 | - | 2.1 | 32,100 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 19.16 per share. | 03 Apr 2023 | 9,172 | 5,828 | - | 19.2 | 175,690 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 19.77 per share. | 03 Apr 2023 | 5,828 | 0 | - | 19.8 | 115,227 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 139,067 | 139,067 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 15,000 | 433,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 01 Mar 2023 | 15,000 | 15,000 | - | 2.1 | 32,100 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 22.71 per share. | 01 Mar 2023 | 5,962 | 9,038 | - | 22.7 | 135,380 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 24.69 per share. | 01 Mar 2023 | 5,316 | 1,050 | - | 24.7 | 131,240 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 23.81 per share. | 01 Mar 2023 | 2,672 | 6,366 | - | 23.8 | 63,623 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 25.67 per share. | 01 Mar 2023 | 1,050 | 0 | - | 25.7 | 26,954 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 15,000 | 448,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 01 Feb 2023 | 15,000 | 15,000 | - | 2.1 | 32,100 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 22.52 per share. | 01 Feb 2023 | 10,505 | 4,495 | - | 22.5 | 236,586 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 23.05 per share. | 01 Feb 2023 | 4,495 | 0 | - | 23.1 | 103,611 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,000 | 463,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 03 Jan 2023 | 15,000 | 15,000 | - | 2.1 | 32,100 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 26.80 per share. | 03 Jan 2023 | 11,927 | 3,073 | - | 26.8 | 319,611 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 27.90 per share. | 03 Jan 2023 | 2,267 | 806 | - | 27.9 | 63,256 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 28.78 per share. | 03 Jan 2023 | 791 | 15 | - | 28.8 | 22,762 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 29.80 per share. | 03 Jan 2023 | 15 | 0 | - | 29.8 | 447 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 01 Dec 2022 | 15,000 | 0 | - | 18 | 270,000 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 01 Dec 2022 | 15,000 | 15,000 | - | 2.1 | 32,100 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 15,000 | 478,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 01 Nov 2022 | 1,038 | 0 | - | 19.5 | 20,241 | Common Stock |
| Jade Biosciences Inc | Timothy P. Noyes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 204,501 | 204,501 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 493,381 | 493,381 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 271,200 | 271,200 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Timothy P. Noyes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 254,253 | 254,253 | - | - | Stock Option (Right to Buy) |